tadalafil has been researched along with Esophageal Achalasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afsharrezaei, F; Bahri, RA; Gholami, M; Shafiee, A; Teymouri Athar, MM | 1 |
1 review(s) available for tadalafil and Esophageal Achalasia
| Article | Year |
|---|---|
Phosphodiesterase 5 (PDE-5) inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review.
Topics: Cyclic Nucleotide Phosphodiesterases, Type 5; Esophageal Achalasia; Humans; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2023 |